Nevada Medicaid and tirzepatide
Zepbound for weight loss: no. Prior authorization for moderate to severe sleep apnea in adults with obesity and no diabetes. Mounjaro for weight loss: no; for type 2 diabetes Nevada Medicaid must cover it. Read from Nevada Health Authority, Nevada Medicaid documents Nov 6, 2026.
In 2025 Nevada Medicaid paid for 19,540 tirzepatide prescriptions (Mounjaro, Zepbound), 28% of its GLP-1 prescriptions and 25th of the 50 states and DC. It reimbursed $22.7 million before rebates, $1,162 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 19,176 | $22.4 million | $1,166 |
| Zepbound | 364 | $346,976 | $953 |
Nevada plans and prescribing rules
Nevada Public Employees' Benefits Program (PEBP). Nevada's PEBP provides weight-loss medications through its voluntary, opt-in Obesity Care Management Program, alongside medically supervised weight loss and nutritional counseling, per its plan year 2026 benefit guide.
Online prescribing. The Nevada State Board of Pharmacy told compounding pharmacies to stop compounding, distributing and dispensing copies of tirzepatide and semaglutide injections once FDA removed both from its shortage list, with May 22, 2025 the last date for outsourcing facilities on semaglutide.
Tirzepatide in the states around Nevada
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Nevada | 17 | $69/moWellmedr | 19,540 | Medicaid Zepbound: No |
| Arizona | 17 | $69/moWellmedr | 6,126 | Medicaid Zepbound: Unclear |
| California | 15 | $69/moWellmedr | 935,362 | Medicaid Zepbound: No |
| Idaho | 17 | $69/moWellmedr | 12,492 | Medicaid Zepbound: Not covered (KFF) |
| Oregon | 17 | $69/moWellmedr | 8,571 | Medicaid Zepbound: No |
| Utah | 17 | $69/moWellmedr | 8,455 | Medicaid Zepbound: Not confirmed (KFF) |



